2009
DOI: 10.1016/j.jhep.2009.03.017
|View full text |Cite
|
Sign up to set email alerts
|

Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
63
0
2

Year Published

2010
2010
2020
2020

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 82 publications
(68 citation statements)
references
References 30 publications
3
63
0
2
Order By: Relevance
“…Our results give a rationale to previous observations in lung cancer and peripheral cholangiocarcinoma whereby FLNA expression correlates with VEGF-A expression (29,30).…”
Section: Discussionsupporting
confidence: 85%
“…Our results give a rationale to previous observations in lung cancer and peripheral cholangiocarcinoma whereby FLNA expression correlates with VEGF-A expression (29,30).…”
Section: Discussionsupporting
confidence: 85%
“…interesting observation is that peripheral-type ICCs show MUC5AC expression less commonly than hilar cholangiocarcinomas. In the study by Guedj et al [29], 32 (62%) of 52 hilar cholangiocarcinomas showed positive MUC5AC immunostaining in contrast to 13 (22%) of 59 peripheral ICCs. Similarly, Aishima et al [28] reported positive MUC5AC staining in 69% to 72% of hilar tumors but in only 25% to 27% of peripheral ICCs (2 different anti-MUC5AC antibodies were used in this study).…”
Section: Discussionmentioning
confidence: 89%
“…Overexpression of MUC5AC in PDA has been reported in 70% to 100% of the cases in several studies [13,14,25]. Similarly, a high frequency of MUC5AC expression has been reported in cholangiocarcinoma [11,13,14,[26][27][28][29] and gallbladder adenocarcinoma [11,15]. In the studies where ICC and extrahepatic cholangiocarcinoma (ECC) were separately evaluated, it was apparent that ECCs more frequently expressed MUC5AC than ICCs.…”
Section: Discussionmentioning
confidence: 99%
“…We retrospectively retrieved, from the files of surgical and pathology departments, the cases of 106 patients who underwent liver resection for intrahepatic cholangiocarcinoma, between 1995 and 2006 at Beaujon Hospital, Clichy, France. The clinicopathological characteristics of these patients have been reported previously (Guedj et al, 2009). In all, 54 patients were men and 52 were women, with a mean age of 59.5 ± 11 years.…”
Section: Immunohistochemical Analysis Of Human Cholangiocarcinomasmentioning
confidence: 96%
“…We found no significant association between EBP50 status and the other clinicopathological features. One possible explanation is that the human cholangiocarcinoma specimens included in our study were from patients who underwent surgical resection and, therefore, had better clinical outcome than is often the case (Guedj et al, 2009). …”
Section: Loss Of Ebp50-egfr Interplay In Biliary Carcinomamentioning
confidence: 98%